Peptide-based materials hold great promise as immunotherapeutic agents for the treatment
of many malignant cancers. Extensive studies have focused on the development of peptide …

Anticancer active immunotherapy embodies the ideal antitumor therapy, as it theoretically
combines target specificity with long-term disease control. Peptide-based cancer vaccines …

Combination therapeutic regimen is becoming a primary direction for current cancer
immunotherapy to broad the antitumor response. Functional nanomaterials offer great …

Antitumor T-cell responses have the potential to be curative in cancer patients, but the
induction of potent T-cell immunity through vaccination remains a largely unmet goal of …

Human tumor-associated antigens are generally weakly immunogenic and therefore able to
escape detection by the immune system. Numerous studies have shown, however, that …

Abstract Poly (lactic-co-glycolic) acid (PLGA) has been successfully used in drug delivery
and biomaterial applications, but very little attention has been directed towards the potential …

A new strategy based on a macrophage-inducible C-type lectin (Mincle) agonist was
established to construct synthetic cancer vaccines. Using sialyl-Tn (STn) as a model antigen …

Amino acid-tuned self-assembly has become an attractive strategy for constructing various
functional materials. Here, a series of dibenzocyclooctyne (DIBO) functionalized amphiphilic …

Cancer is the leading cause of death worldwide. In developed as well as developing
countries, breast cancer is the most common cancer found among women. Currently …

Simple Summary Cancer vaccination is a potential anti-cancer therapy which may improve
clinical outcomes, particularly in combination with current immunotherapies, but to date has …